MedTrace Logo

cArdiopulmonary exerCise Test Assessing Multiple bIOmarkers iN Type 1 Diabetes

NCT05097339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2021-10-28

No results posted yet for this study

Summary

Collection of venous blood samples in male T1D patients to evaluate the behavior of different biomarkers (beta-hydroxybutyrate, lactate, glucose) during and after morning Aerobic (60% of VO2 max) and Symptom Limited Maximal Exercise Test.

Conditions

  • Diabetes Mellitus, Type 1

Sponsors & Collaborators

  • Indigo Diabetes NV

    collaborator INDUSTRY

  • Université Montpellier

    collaborator OTHER

  • Campus Bio-Medico University

    collaborator OTHER

  • University of Padova

    collaborator OTHER

  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Christophe De Block, MD, PhD · University Hospital, Antwerp

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2020-05-13
Completion
2020-05-13

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05097339 on ClinicalTrials.gov